Cannabis Investing Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
Cannabis Investing Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD
Cannabis Investing Kalytera Announces Further Payments in Shares under Payments Agreements with Salzman Group
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
